Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Wells Fargo analyst Stephen Baxter maintains Molina Healthcare (NYSE:MOH) with a Overweight and lowers the price target from...
Health insurer stocks fell after the Senate ended the shutdown without extending ACA subsidies, delaying the decision to Decemb...
Wall Street rebounded on Monday, recovering part of last week's steep losses as investors grew more confident about risk as...
Michael Burry's Scion Asset Management filed an updated 13F showing a new large bearish position in Palantir and Nvidia, am...
Goldman Sachs analyst Scott Fidel maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $2...
UBS analyst Kevin Caliendo maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from $180 to $170.
Cantor Fitzgerald analyst Sarah James maintains Molina Healthcare (NYSE:MOH) with a Neutral and lowers the price target from...
